Recombinant Human LILRB1 (C-6His)

Description

EnkiLife provides the Recombinant Human LILRB1 (C-6His) protein,aslo know as Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 1,LIR-1,Leukocyte Immunoglobulin-Like Receptor 1,CD85 Antigen-Like Family Member J,Immunoglobulin-Like Transcript 2,ILT-2,Monocyte/Macrophage Immunoglobulin-Like Receptor 7,MIR-7,CD85j,LILRB1,ILT2,LIR1,MIR7, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 1 is produced by our Mammalian expression system and the target gene encoding Gly24-His458 is expressed with a 6His tag at the C-terminus.Accession:ADJ55949.1. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:48.24 KDa. Background:The immunoglobulin-like transcript (ILT) family (also named leukocyte Ig-like receptors (LIR) and monocyte/macrophage Ig-like receptors (MIR)) can be activating and inhibitory immunoreceptors. ILTs are expressed on many leukocyte subsets and regulators of immune responses . ILTs share significant homology with killer cell Ig-like receptors (KIR). Except ILT-6, all ILT family members are type I transmembrane proteins having two or four extracellular Ig-like domains . ILT2 is expressed on most monocytes,dendritic cells,and mature B cells. ILT2 is also expressed on small percentages of T-cells and NK cells. ILT2 can prevents cellular activation.